Odds Ratios of Metabolic Monitoring by Provider Type, Florida and Texas Combined (2017)
| Provider Variables . | Overall (Texas and Florida Combined) . | Adjusted Model by State . | State and Provider Interaction, P . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Unadjusteda . | Adjustedb . | Florida . | Texas . | ||||||
| Odds Ratio (95% CI) . | P . | Odds Ratio (95% CI) . | P . | Odds Ratio (95% CI) . | P . | Odds Ratio (95% CI) . | P . | ||
| During the year, ≥1 visit | .0319 | ||||||||
| PCP | Reference | — | Reference | — | Reference | — | Reference | — | — |
| MHP | 0.80 (0.73–0.89) | <.001 | 0.77 (0.69–0.86) | <.001 | 0.64 (0.54–0.76) | <.001 | 0.87 (0.75–1.00) | .055 | — |
| PCP and MHP | 1.72 (1.62–1.82) | <.001 | 1.42 (1.32–1.52) | <.001 | 1.31 (1.16–1.47) | <.001 | 1.47 (1.35–1.60) | <.001 | — |
| Majority prescribing provider | .2709 | ||||||||
| PCP | Reference | — | Reference | — | Reference | — | Reference | — | — |
| MHP | 1.45 (1.36–1.54) | <.001 | 1.25 (1.17–1.33) | <.001 | 1.19 (1.05–1.34) | .006 | 1.27 (1.18–1.38) | <.001 | — |
| Other | 1.21 (1.11–1.33) | <.001 | 1.20 (1.08–1.32) | <.001 | 1.25 (1.07–1.45) | .005 | 1.14 (1.00–1.30) | .048 | — |
| Provider Variables . | Overall (Texas and Florida Combined) . | Adjusted Model by State . | State and Provider Interaction, P . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Unadjusteda . | Adjustedb . | Florida . | Texas . | ||||||
| Odds Ratio (95% CI) . | P . | Odds Ratio (95% CI) . | P . | Odds Ratio (95% CI) . | P . | Odds Ratio (95% CI) . | P . | ||
| During the year, ≥1 visit | .0319 | ||||||||
| PCP | Reference | — | Reference | — | Reference | — | Reference | — | — |
| MHP | 0.80 (0.73–0.89) | <.001 | 0.77 (0.69–0.86) | <.001 | 0.64 (0.54–0.76) | <.001 | 0.87 (0.75–1.00) | .055 | — |
| PCP and MHP | 1.72 (1.62–1.82) | <.001 | 1.42 (1.32–1.52) | <.001 | 1.31 (1.16–1.47) | <.001 | 1.47 (1.35–1.60) | <.001 | — |
| Majority prescribing provider | .2709 | ||||||||
| PCP | Reference | — | Reference | — | Reference | — | Reference | — | — |
| MHP | 1.45 (1.36–1.54) | <.001 | 1.25 (1.17–1.33) | <.001 | 1.19 (1.05–1.34) | .006 | 1.27 (1.18–1.38) | <.001 | — |
| Other | 1.21 (1.11–1.33) | <.001 | 1.20 (1.08–1.32) | <.001 | 1.25 (1.07–1.45) | .005 | 1.14 (1.00–1.30) | .048 | — |
CI, confidence interval; —, not applicable.
Unadjusted odds ratios are derived from the GEE model (accounting for most seen NPIs during the year) of only the individual provider variable and including only state as a covariate.
Adjusted odds ratios are derived from GEE models described above with both provider variables but also include as covariates the following patient characteristics: indicator of whether the behavioral health diagnosis is an accepted condition for use of antipsychotic, any cardiometabolic diagnosis (described in a footnote for Table 1), enrolled in foster care, age, sex, race and/or ethnicity, RUCC category, and SVI quartile.